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a b s t r a c t
The major burden of inﬂuenza morbidity resides within the elderly population. The challenge managing
inﬂuenza-associated illness in the elderly is the decline of immune function, where mechanisms leading
to immunological senescence have not been elucidated. To better represent the immune environment,
we investigated clinical morbidity and immune function during sequential homologous and hetero-
logous H1N1 inﬂuenza infection in an aged ferret model. Our ﬁndings demonstrated experimentally that
aged ferrets had signiﬁcant morbidity during monosubtypic heterologous 21 challenge with signiﬁcant
weight loss and respiratory symptoms. Furthermore, increased clinical morbidity was associated with
slower and shorter hemagglutinin antibody generation and attenuated type 1 T-cell gene responses in
peripheral blood. These results revealed dampened immune activation during sequential inﬂuenza
infection in aged ferrets. With the presence of an aged model, dissecting clinical morbidity, viral
dynamics and immune response during inﬂuenza infection will aid the development of future
prophylactics such as age speciﬁc inﬂuenza vaccines.
& 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
Introduction
The elderly inﬂuenza disease rate in humans carries a heavy
burden on healthcare systems and perpetuates virus circulation in
the general population. During the 2012–2013 season, persons agedZ
65 years accounted for 50% of all inﬂuenza-related hospitalizations
in the US (Centers for Disease Control and Prevention (CDC), 2013).
Since the host immune system deteriorates signiﬁcantly during aging,
the inability to generate effective, broad-spectrum immune memory
following infection or vaccination contributes to increased inﬂuenza
burden among the elderly (Bridges et al., 2000; Castle, 2000; Dao
et al., 2010; Thompson et al., 2003). Aging inﬂuences various facets of
the immune response, but T-cell populations are prominently affected
due to thymus involution limiting naïve T-cell production (Aw and
Palmer, 2011; Buchholz et al., 2011; Castle, 2000). Post-thymic
homeostatic T-cell proliferation compensates for production deﬁcit
(Aw and Palmer, 2011; Buchholz et al., 2011), but long-term T-cell
replication leads to cell-intrinsic dysfunction highlighted by progres-
sive loss of repertoire diversity and weakened responses (Buchholz
et al., 2011). This directly inﬂuences cell-mediated T-cell responses,
most evident during viral infection (Buchholz et al., 2011; Deng et al.,
2004; Effros et al., 2003), while indirectly affecting humoral responses
(Eaton et al., 2004). Together with high rates of antigenic change of
circulating virus population, this process puts the elderly at greater
risk of recurring inﬂuenza infection (Bridges et al., 2000).
Age-related immune dysregulation modestly impacts disease
severity in animal models of primary inﬂuenza infection (Guo
et al., 2012; Josset et al., 2012; Muto et al., 2012; Pica et al., 2012).
Heterosubtypic inﬂuenza A immune memory is severely impaired
in aged animals (Bender and Small, 1993; Decman et al., 2010),
although the elderly's sensitivity to monosubtypic antigenic
change is unclear. To address this question, we investigated clinical
morbidity, viral dynamics, and subsequent immune responses to
sequential inﬂuenza A H1N1 infection for the ﬁrst time in an aged
ferret model. Here we report dampened immunity in aged ferrets
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upon monosubtypic heterologous 21 challenge associated with
diminished antibody production and altered T-cell responses in
peripheral blood. These ﬁndings help elucidate the immune
dynamics which contribute to elderly inﬂuenza susceptibility
and put forth the aged ferret model for further study of aging
immunity and inﬂuenza.
Results
Aged ferrets develop more severe disease than adults during
heterologous monosubtypic 21 challenge
Ferrets closely mimic the clinical manifestations of inﬂuenza
infection in humans as shown previously (Banner and Kelvin,
2012; Belser et al., 2011; Huang et al., 2011, 2013; Rowe et al.,
2010). Naïve adult (4–6 months old) and aged (Z4 years old) male
ferrets were placed into groups for either homologous or hetero-
logous H1N1 sequential infection studies. The homologous
sequentially infected group was ﬁrst infected intranasally with
pandemic 2009 H1N1 strain A/Mexico/4108/2009 (Mex/4108) as
the 11 infection after 46 days the animals were then infected with
pandemic 2009 H1N1 A/California/07/2009 (Cal/07) as 21 chal-
lenge. The heterologous 11 infection–21 challenge group was
infected with seasonal H1N1 A/Brisbane/59/2007 (Bris/59) and
then subsequently infected with Mex/4108 Day 39 post 11 infec-
tion. Animals were intranasally infected with the indicated virus
strain at 106 EID50 and clinical signs were monitored for 14 days
post-infection/challenge (temperature, weight change, nasal dis-
charge (clear discharge or color dry mucus/exudate), sneezing, and
lethargy).
During both 11 strain infections aged animals exhibited clinical
morbidity that was modestly more pronounced than in adults,
with greater weight loss (7–8% peak loss) and more frequent
production of mucus/exudate. Sneezing was also observed more
frequently in our aged cohorts, but sneezing incidence rates in
aged ferrets (50%) were consistent with previously reported rates
in adults during sH1N1 or H1N1pdm infection (Huang et al., 2011).
Upon homologous 21 challenge with Cal/07, neither age group
exhibited clinical symptoms except for sporadic detection of clear
nasal discharge and sneezing (Fig. 1A). In contrast, during hetero-
logous 21 challenge with Mex/4108, adult ferrets showed mild
clinical morbidity whereas the aged animals developed greater
illness with 46% peak weight loss, sneezing, prominent nasal
discharge (yellow–brown color exudate or dry mucus), and
lethargy.
Having detected disease differences between aged and adult
ferrets during sequential inﬂuenza infection, we next examined if
morbidity was associated with viral burden in nasal washes. Live
virus titers were measured at Days 3 and 7. No signiﬁcant
differences in viral burden/clearance were detected between the
age groups at any time-point tested. Virus was undetectable by
Day 3 following homologous 21 challenge in both age groups.
Mex/4108 virus titers were dramatically reduced at Day 3 post-
heterologous 21 challenge when compared to 11 infection ( 100-
fold), consistent with previous reports (Fang et al., 2012) (Fig. 1C).
Interestingly, aged animals still developed severe clinical morbid-
ity during heterologous 21 challenge (Fig. 1B) despite reduced viral
titers.
Antibody production in aged ferrets is delayed and not sustained
at levels equivalent to adults
The increased disease severity in aged ferrets during hetero-
logous 21 challenge prompted us to investigate possible causes of
the disease disparity between aged and adult animals. Roles for
humoral (Fang et al., 2012) and cell-mediated immunity (Guo
et al., 2011; Tu et al., 2010) have been identiﬁed in heterologous
inﬂuenza A H1N1 rechallenge models. First we investigated
humoral responses in our cohort by assaying sera taken from the
ferrets at designated time points for haemagglutination inhibition
(HI) against Bris/59 or Mex/4108 viruses. Aged ferrets failed to
maintain antibody titers at the same levels as adults following
either 11 Bris/59 or Mex/4108 infection. By Day 28 post Mex/4108
11 infection, aged ferrets had signiﬁcantly reduced haemagglutinin
antibody levels compared to adults which remained signiﬁcantly
lower through the 21 infection with Cal/07 (Fig. 2A). Aged ferrets
were also slower to mount an initial humoral response to the Bris/
59 virus during 11 infection, as adults had generated antibodies
toward Bris/59 by Day 7 post-infection whereas aged animals had
undetectable levels (Fig. 2B). Similar antibody responses were seen
between adult and aged ferrets during the 21 challenge with the
Mex/4108 virus. Together, these results show that aged ferrets
respond differently (slower and less) compared to adult ferrets in
respect to protective antibody generation which may be depen-
dent on the virus strain and the sequence of insult.
Peripheral type 1 T-cell gene responses to heterologous monosubtypic
21 challenge are attenuated in aged ferrets
We next investigated other peripheral immune responses to
complement the humoral immunity evaluation. Host gene expres-
sion analysis for the molecular dissection of circulating immune
cell regulation (Fig. 3) was performed on in-life peripheral blood
samples taken from animals throughout the infection time course.
In our analysis we included gene sets for cell mediated immunity,
inﬂammatory cytokines and T cell regulation. Strikingly, we
detected rapid increases in CD4 and CD8 mRNA expression during
heterologous 21 challenge in adult but not aged ferrets, with peak
differences in CD4 (2-fold) and CD8 (3-fold) expression detected at
Day 1 post-21 challenge (p21) (Fig. 3B (i and ii)). A similar
expression proﬁle was detected for CD28 (T-cell activation cell
surface marker) with signiﬁcantly higher expression in adults.
(Fig. 3B (iii)). Together, these proﬁles suggested rapid mobilization
of adult T-cells to peripheral blood during heterologous challenge
which was diminished in the aged. Moreover, we also detected a
trend of reduced CD19 (B-lymphocyte maker) expression in aged
ferrets (Fig. 3B (iv)), consistent with impaired humoral responses
as suggested by our HI data. In contrast, similar innate response
gene proﬁles (CXCL8, CXCL10, and TLR3) were detected in both
groups with mostly no changes in gene regulation throughout the
time course except for acute upregulation of CXCL8 and CXCL10
during heterologous 21 challenge at Day 1 p21 (Fig. 3 (v–vii))
(2-fold and 10–20-fold increase, respectively).
Given the role of type 1 T-cell responses in heterologous
immunity (Guo et al., 2011; Tu et al., 2010), we further investigated
circulating T-cell population effector status by measuring TBX21
(transcription factor expressed in Th1-commited CD4þ T-cells and
CD8þ T-cells) (Sullivan et al., 2003; Szabo et al., 2000), GZMA
(cytotoxic T-cell effector molecule) (Anthony et al., 2010), as well
as IFNγ and TNFα (type 1 cytokines) (Grivennikov et al., 2005;
Xu et al., 2004) levels (Fig. 3(viii–xi)). As above, TBX21 and TNFα
mRNA expression declined early (Day 1 p21) during heterologous
21 challenge in aged ferrets while remaining stable in adult ferrets
(TBX21: 2-fold) (TNFα: 2-fold) (Fig. 3B (viii and x)). Furthermore,
peak GZMA mRNA expression was reduced in aged ferrets (Fig. 3
(ix)). Together, these ﬁndings suggest a potential age-related
decrease in type 1 T-cell responses speciﬁc to heterologous 21
challenge which may have contributed to disease (Bender and
Small, 1993; Decman et al., 2010).
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Fig. 1. Aged ferrets exhibited increased clinical morbidity during heterologous 21 challenge. Clinical sign monitoring of aged (44 years old) and adult (4–6 months old)
ferrets during homologous [11: A/Mexico/4108/2009 (H1N1); 21: A/California/07/2009 (H1N1)] (A) or heterologous [11: A/Brisbane/59/2007 (H1N1); 21: A/Mexico/4108/2009
(H1N1)] monosubtypic sequential infections (B). All infections at 106 EID50. Temperature and weight were recorded daily following 11 infection until Day 5 post-infection
(pi), then at Days 7, 10, and 14 pi. Temperature and weight were recorded daily after 21 challenge for 14 days. Both are reported as a percentage relative to the average
preinfection level calculated from Days 0 and 1. Animals were also evaluated daily for nasal discharge, sneezing, and inactivity level, and the highest percentages (and
fractions [number of ferrets displaying symptoms/total number of ferrets tested]) of infected ferrets displaying symptoms are shown. The physical inactivity index measures
the degree to which ferrets respond to environmental stimuli, with the basal level being 1.000. Viral titers were measured in nasal washes collected from aged and adult
ferrets at Days 3 and 7 after 11 infection and 21 challenge and determined by titration on MDCK cells and reported as TCID50/mL (C).
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Discussion
Our study revealed increased disease severity in aged ferrets
during sequential heterologous H1N1 inﬂuenza infection which
was associated with altered aged T-cell responses and antibody
production (Fig. 4). Our data suggested modulation of T-cell
function during vaccination as a potential target for improving
elderly immune memory against inﬂuenza, and recommends the
aged ferret inﬂuenza model for the development of immunomo-
dulatory inﬂuenza therapeutics and vaccines. Moreover, antibody
titers in aged ferrets were not sustained at the same levels
observed in adults which may also be a consequence of dampened
T cell responses and should be further explored. The elderly have
the highest inﬂuenza-related hospitalization rates placing stress
on healthcare systems and increasing virus exposure to other
members of the community such as hospital works and other
hospitalized patients. Better management of inﬂuenza infection in
the older population is urgently needed. Boosting elderly T-cell
responses may be a valuable therapeutic target for broadening of
immune memory.
The analysis of clinical symptoms in aged versus adult ferrets
was highly insightful and recapitulated the clinical disease course
observed in elderly humans as well as other animal studies. Here
we found that aged ferrets did not recover to their original weight
following sequential heterologous H1N1 inﬂuenza infection
(Fig. 4), a ﬁnding consistent with observations of long-term
disability in the elderly following repeated inﬂuenza exposure
(McElhaney, 2005). Clinical signs in our aged ferret model were
also in agreement with previous animal studies where the disease
severity of aged animal was modestly increased during 11 infec-
tion (Guo et al., 2012; Josset et al., 2012; Muto et al., 2012; Pica
et al., 2012) but importantly, heterologous monosubtypic 11
infection–21 challenge caused severe morbidity in aged ferrets
similar to previous rechallenge mouse studies (Bender and Small,
1993; Decman et al., 2010). Our work together with previously
published studies has begun to suggest a proﬁle of the aged
clinical following subsequent inﬂuenza infection.
Along with a more severe clinical proﬁle, aged ferrets had an
attenuated peripheral humoral and T cell immune response
compared to adults and previously modeled immune responses
following inﬂuenza infection (Cheng et al., 2013; Huang et al.,
2011; Jang et al., 2013; Kelvin et al., 2014; O’Donnell et al., 2012;
Paquette et al., 2014). We found aged ferrets to have a signiﬁcant
decrease in sustained HA antibody production following 11 and
continued into secondary 21 pandemic H1N1 infection which may
indicate a factor in the increased susceptibility to sequential
inﬂuenza infections in the elderly. Also, aged ferrets were mark-
edly slower to mount an initial humoral response to the Bris/59
virus during 11 infection where antibody levels remained unde-
tected 7 days following infection which may play a role in
prolonged disease in our aged ferrets. Conversely, we found that
the 11 Mex/4108 infection did not show differential HA antibody
generation. It is possible that higher viral titers detected during
Mex/4108 versus Bris/59 11 infection (100-fold at Day 3) may
have masked humoral deﬁciencies in the aged cohort. Alterna-
tively, these disparate data sets may indicate inﬂuenza strain-
speciﬁc immune responses in aged ferrets which could be further
investigated. A protective role for cross-reactive antibodies has
been identiﬁed during sequential inﬂuenza A H1N1 infection (Fang
et al., 2012) and it is possible in aged animals that lower antibody
titers may have contributed to the increased disease severity
observed during heterologous 21 challenge.
Interestingly, peripheral T cell responses in the aged ferrets also
appeared to be dampened as determined by real-time RT-PCR.
Speciﬁcally, CD4, CD8, and CD28 were signiﬁcantly more robust in
the adults compared to the aged during 11 Bris/59–21 Mex/4108
infection combination. Previous reports in humans and other
mammals have suggested T-cell responses are impaired in the
elderly (Aw and Palmer, 2011; Buchholz et al., 2011). Similarly, we
detected attenuated type 1 T-cell gene responses in aged ferret
peripheral blood which may indicate intrinsic differences in the
aged ferret T-cell population. Reduced antibody titers in aged
ferrets may also have been a consequence of impaired T-cell
function (Eaton et al., 2004; Haynes et al., 2005). Together, these
observations suggest altered T-cell populations and/or activity in
aged ferrets may have limited the breadth of immune memory
following 11 infection, recommending additional investigation of
the aged ferret T-cell population. Reduced T-cell proliferation and
interleukin-2 production in response to antigen have been linked to
immune decline in aged mice (Decman et al., 2010; Deng et al., 2004;
Fig. 2. Antibody production in aged ferrets was delayed and not maintained at adult levels. Antibody titers against live A/Mexico/4108/2009 (H1N1) and A/Brisbane/59/2007
(H1N1) viruses were determined by HI assay for aged and adult ferret sera collected at the indicated days post-11 infection and 21 challenge. Error bars represent standard
errors of the means. npo 0.05 by Student's t test comparing infected adult and aged ferrets.
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Haynes et al., 2005) and these should be investigated further in aged
ferrets. Aging has also been associated with declines in T-cell
repertoire diversity (Buchholz et al., 2011; Naylor et al., 2005;
Yager et al., 2008) which may be attributable in part to reduced
naïve T-cell production (Aw and Palmer, 2011; Buchholz et al., 2011;
Castle, 2000) and gradual deletion of low-avidity T-cell clones as
peripheral T-cell expansion is increasingly biased towards high-
avidity clones with age (Rudd et al., 2011). Loss of clonal diversity
in aged mice has been shown to impair heterosubtypic immunity
(Yager et al., 2008) and may have similarly contributed to the weaker
memory responses detected in aged ferrets during heterologous 21
infection. Accordingly, changes in the T-cell repertoire during ferret
aging should also be the focus of future work. Meanwhile, our data
provides indication that boosting T-cell responses to antigen during
vaccination of the elderly may help limit susceptibility to severe
inﬂuenza infection. Studies in human cells ex vivo and in mice have
shown that increasing inﬂammatory cytokine production by antigen
presenting cells improves aged T-cell responses to antigen (Behzad et
al., 2012; Jones et al., 2010). Accordingly, the aged ferret model
described here may serve as a valuable tool for the future develop-
ment of such immune boosting therapies. Further study of aged T-
cell function during sequential inﬂuenza infection in ferrets may also
reveal more direct therapeutic targets.
Inﬂuenza disease rates are increased among the elderly due in
part to a failure in generating broad, long-lasting immunity
following inﬂuenza exposure (Bridges et al., 2000; Castle, 2000;
Centers for Disease Control and Prevention (CDC), 2013; Dao et al.,
2010; Thompson et al., 2003). New approaches to improve elderly
immune responses and immune memory are needed, yet aged
animal models for the study of inﬂuenza infection and immunity
are limited (Bender and Small, 1993). Our data puts forth the aged
ferret inﬂuenza model and showed that aged ferrets failed to
mount an equivalent immune response as adults to monosubtypic
heterologous 21 challenge which was associated with altered
peripheral T-cell responses, decreased antibody production, and
increased morbidity.
Materials and methods
Ethics statement
Animal work was performed in strict accordance with the
Canadian Council of Animal Care (CCAC) guidelines. The animal
use protocol was approved by the Animal Care Committee (ACC) of
the University Health Network (UHN) where UHN has certiﬁcation
with the Animals for Research Act (Permit Number: #0045 and
#0085 of the Ontario Ministry of Agriculture, Food and Rural
Affairs) and follows NIH guidelines (OLAW #A5408-01). Infections
and subsequent sample collection were performed under 5%
isoﬂuorane anesthesia in an effort to minimize suffering.
Animal infections and clinical monitoring
Ferrets were bred and housed in an on-site speciﬁc-pathogen-
free facility (UHN, Toronto, ON, Canada). Adult ferrets were
deﬁned as 4–6 months of age, while aged ferrets were deﬁned
as44 years of age (all male). All ferrets were tested for the
presence of antibodies against circulating inﬂuenza A and B virus
strains by HI and shown to be seronegative prior to infection.
Fig. 3. Type 1 T-cell gene responses detected in peripheral blood of adult but not aged
ferrets upon heterologous 21 challenge. Gene expression analysis from peripheral blood
total RNA collected from aged and adult ferrets at Days 0, 3, 7, and 14 during 11 infection
and Days 0, 1, 3, and 7 during 21 challenge. Expression levels of CD4 (i), CD8 (ii),
CD28 (iii), CD19 (iv), CXCL8 (v), CXCL10 (vi), TLR3 (vii), TBX21 (viii), GZMA (ix), TNFα (x),
IFNγ (xi), and CD44 (xii) mRNA were determined by qRT-PCR, normalized to house-
keeping gene β-Actin and expressed as fold change difference in expression relative to
Day 0 adult basal levels. Three samples from each time point were collected per group.
Error bars represent standard errors of the means. npo 0.05 by Student's t test
comparing infected adult and aged ferrets.
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Infection experiments were conducted with H1N1pdm strains
A/Mexico/4108/2009 (H1N1) and A/California/07/2009 (H1N1) or
sH1N1 strain A/Brisbane/59/2007 (H1N1). All viruses were pro-
vided by the Centers for Disease Control and Prevention ([CDC],
Atlanta, GA, USA). Viral stocks were propagated in embryonated
eggs for no more than one passage, stored in liquid nitrogen, and
thawed prior to use. All 11 infections and 21 challenges were
performed at 106 EID50. Infections and daily clinical sign monitor-
ing were performed as previously described (Huang et al., 2012).
Viral and humoral kinetics
Nasal washes were collected at Days 3 and 7 post-infection/
challenge and viral titers were determined by titration over
Madin-Darby Canine Kidney (MDCK) cells and TCID50/mL calcula-
tion using the Reed–Muench method (Huang et al., 2012). In-life
bleeds were performed at designated time-points for isolation of
sera and determination of antibody titers against Bris/59 and Mex/
4108 haemaggultinin by HI assay, as previously described (Huang
et al., 2012).
Peripheral blood gene expression analysis
In-life bleeds were performed at designated time-points for
isolation of peripheral blood total cellular RNA. Blood was col-
lected in PAXgene Blood RNA tubes and stored at 80 1C until
extraction by PAXgene Blood RNA Kit (PreAnalytiX,
Hombrechtikon, Switzerland), as per manufacturer's instructions.
Puriﬁed RNA was reverse transcribed using ImProm-II Reverse
Transcription System (Promega, Madison, WI, USA) and host gene
expression was investigated by qRT-PCR using ABI-Prism 7900HT
Sequence Detection Systems (Applied Biosystems, Foster City, CA,
USA). Each sample was run in quadruplicate at 5 ng cDNA/reaction
well. Host gene expression was normalized to β-actin, and
quantiﬁed by the relative standard curve method. Primer
sequences are listed in Table S1.
Statistical methods
The Student's t-test (α¼0.05) was used to ascertain signiﬁ-
cance for two group comparisons, assuming two-tailed distribu-
tions and unequal variances.
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